Knockout Corner: 5-HT1A receptor inactivation: Anxiety or depression as a murine experience

International Journal of Neuropsychopharmacology

Volumn 2, Issue 4, 1999, Pages 327-331

  Lesch, Klaus Peter ^a   Mössner, Rainald ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

Anxiety; Depression; Gene knockout; Serotonin receptor 1A

Indexed keywords

EID: 0000742988     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145799001662     Document Type: Article

References (27)

1. Artigas F, Romero L, de Montigny C, Blier P (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences 19, 378-383.
2. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A Mossner R, Westphal H, Lesch KP (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Molecular Pharmacology 53, 649-655.
3. Berlin I, Warot D, Legout V, Guillemant S, Schollnhammer G, Puech AJ (1998). Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Clinical Pharmacology and Therapeutics 63, 428-436.
4. Blier P, Bergeron R, de Montigny C (1997). Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16, 333-338.
5. Blier P, de Montigny C (1998). Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biological Psychiatry 44, 313-323.
6. Fabre V, Rioux A, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Marres MP (In Press). Altered expression and coupling of the serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. European Journal of Neuroscience.
7. Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988). Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. Journal of Pharmacology and Experimental Therapeutics 246, 745-752.
8. Hamon M, Gozlan H, El Mestikawy S, Emerit MB, Boanos F, Schlechter L (1990). The central 5-HT1A receptors: pharmacological, biochemical, functional and regulatory properties. Annals of the New York Academy of Science 600, 114-131.
9. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences USA 95, 15049-15054.
10. Kash SF, Tecott LH, Hodge C, Baekkeskov S (1999) Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proceedings of the National Academy of Sciences USA 96, 1698-1703.
11. Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L (In Press). Differential adaption of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology.
12. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995). Early desensitization of somatodendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Archives of Pharmacology 352, 141-148.
13. Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME (1999). 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20, 628-639.
14. Lesch KP, Hoh A, Schulte HM, Osterheider M, Muller T (1991). Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105, 415-420.
15. Lesch KP, Mössner R (1998). Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders. Biological Psychiatry 44, 179-192.
16. Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD (1993). Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist 8-OH-DPAT in male rats. Brain Research 630, 148-156.
17. Li Q, Muma NA, Battaglia G, Van de Kar LD (1997). A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(1) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. Journal of Pharmacology and Experimental Therapeutics 282, 1581-1590.
18. Li Q, Wiches C, Heils A, Van de Kar LD, Lesch KP, Murphy DL (In Press). Reduction of 5-HT1A-mediated temperature and neuroendocrine responses and 5-HT1A binding sites in 5-HT transporter knockout mice. Journal of Pharmacology and Experimental Therapeutics.
19. Murphy DL, Wichems C, Li Q, Heils A (1999). Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends in Pharmacological Science 20, 246-252.
20. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM (1992). Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Biotechnology 24, 429-433.
21. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). Increased anxiety of mice lacking the serotoninlA receptor. Proceedings of the National Academy of Sciences USA 95, 10734-10739.
22. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences USA 95, 14476-14481.
23. Romero L, Hervas I, Artigas F (1996). The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters 219, 123-126.
24. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998). Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. Journal of Neuroscience 18, 3035-3042.
25. Sargent P, Williamson DJ, Pearson G, Odontiadis J, Cowen PJ (1997). Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity. Psychopharmacology (Berlin) 132, 296-302.
26. Sprouse JS, Aghajanian GK (1986). (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. European Journal of Pharmacology 128, 295-298.
27. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genetics 19, 162-166.